SCHEDULE 14A
                    Proxy Statement Pursuant to Section 14(a)
            of the Securities Exchange Act of 1934 (Amendment No. __)


Filed by the Registrant [ ]

Filed by a Party other than the Registrant    [x]

Check the appropriate box:

[  ]     Preliminary Proxy Statement
[  ]     Confidential, for Use of the Commission Only (as permitted by 
         Rule 14a-6(e)(2))
[  ]     Definitive Proxy Statement
[  ]     Definitive Additional Materials
[X ]      Soliciting Material Pursuant to ss. 240.14a-12

                             Mylan Laboratories Inc.
                                                                 
                (Name of Registrant as Specified In Its Charter)

                                 Carl C. Icahn,
                   Barberry Corp., Hopper Investments LLC and
                         High River Limited Partnership

                                                                 
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (check the appropriate box):

[X]      No fee required.

[   ]    Fee computed on table below per Exchange Act Rule 14a-6(i)(4) and 0-11.

     1) Title of each class of securities to which transaction applies:

                                                                 

     2) Aggregate number of securities to which transaction applies:

                                                                 

     3) Per unit  price  or  other  underlying  value  of  transaction  computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee
is calculated and state how it was determined):

                                                                 

         4)       Proposed maximum aggregate value of transaction:

                                                                 

         5)       Total fee paid:

                                                                 

[  ]     Fee paid previously with preliminary materials.

[  ]     Check box if any part of the fee is offset as provided by Exchange  Act
Rule  0-11(a)(2)  and identify the filing for which the offsetting fee was paid
previously.  Identify the previous filing by  registration  statement number, 
or the Form or Schedule and the date of its filing.

     1) Amount Previously Paid:

                                                                 

     2) Form, Schedule or Registration Statement No.:

                                                                 

     3) Filing Party:

                                                                 

     4) Date Filed:

                                                            

     Carl Icahn's letter to the Editor of the New York Times was published on 
December 5, 2004 and is attached hereto.




     SECURITY  HOLDERS  ARE  ADVISED  TO READ  THE  PROXY  STATEMENT  AND  OTHER
DOCUMENTS  RELATED TO  SOLICITATION  OF PROXIES BY MR. ICAHN AND HIS  AFFILIATES
FROM THE STOCKHOLDERS OF MYLAN  LABORATORIES INC. FOR USE AT ITS SPECIAL MEETING
WHEN  AND  IF  THEY  BECOME  AVAILABLE   BECAUSE  THEY  WILL  CONTAIN  IMPORTANT
INFORMATION.  WHEN COMPLETED,  A DEFINITIVE  PROXY STATEMENT AND A FORM OF PROXY
WILL BE MAILED TO STOCKHOLDERS OF MYLAN  LABORATORIES INC. AND WILL BE AVAILABLE
AT  NO  CHARGE  AT  THE   SECURITIES  AND  EXCHANGE   COMMISSION'S   WEBSITE  AT
HTTP://WWW.SEC.GOV.   INFORMATION  RELATING  TO  THE  PARTICIPANTS  IN  A  PROXY
SOLICITATION  IS  CONTAINED  IN THE  SCHEDULE  14A  FILED BY MR.  ICAHN  AND HIS
AFFILIATES WITH THE SECURITIES AND EXCHANGE  COMMISSION ON OCTOBER 14, 2004 WITH
RESPECT TO MYLAN  LABORATORIES INC. THAT SCHEDULE 14A IS CURRENTLY  AVAILABLE AT
NO CHARGE ON THE SECURITIES AND EXCHANGE COMMISSION'S WEBSITE.






The Investment
And the Follow-Through

To the Editor:

Re "For a Takeover Artist, One Bluff Too Many?" (DealBook,  Nov. 28), about
my bid for Mylan Laboratories, which is aiming to buy King Pharmaceuticals:

In the  column,  Andrew  Ross  Sorkin  states  that I have  made a  fortune
"threatening  to take over  companies  and then rarely  going  through  with the
proposition." The facts prove this statement to be ridiculous. I have never made
a bid for a company and not followed through with a binding offer when given the
customary due diligence.

During the last three years alone,  after making  bids,  we have  purchased
outright or purchased control in XO Communications, for $500 million; Allegiance
Telecom, for $670 million; Philip Services, for $170 million; the TransTexas Gas
Corporation;  and  Panaco  Inc.  Additionally,  we  have  purchased  many  other
companies during the last two decades.

The column further stated: "A bevy of hedge funds, led by Perry Capital and
Citadel,  which had bought  King  shares in the hope that the deal with Mylan is
completed,  have started  buying  shares of Mylan to help push the deal through.
But  to  protect   themselves,   some  of  these   investors  have  begun  using
sophisticated  swap  trades  with banks so that they have no exposure to Mylan's
stock price.  This way, the investors  have voting  power,  but no real economic
interest in Mylan."

Mr.  Sorkin  describes  the  actions  by these  hedge  funds  as a  "fairly
innovative maneuver."

On Monday,  Perry  Capital  disclosed in a filing with the  Securities  and
Exchange Commission that it has hedged its Mylan shares,  apparently  confirming
earlier  reports that Perry may have had no economic  interest in Mylan,  merely
the right to vote those shares. If this is true, in our opinion,  this so-called
innovative  maneuver is co-opting the election process and robbing  shareholders
of the right to have a meaningful vote.

Corporate  democracy is a cornerstone of our capitalist system. A few hedge
funds should not be permitted to destroy it in order to make a few extra bucks.

Carl Icahn
New York, Nov. 30